PRLD vs UTHR · rev $10.3M vs P/E 20, rev $1.56B
Prelude Therapeutics Inc (PRLD) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PRLD revenue for 2026-06-30 was $10.3M. Net income was -$24.3M. PRLD currently screens at market cap $346.5M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
PRLD currently screens at market cap $346.5M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the PRLD and UTHR stock pages for the full models.
Not investment advice.